Get started
Author

Cyril Šálek

Observed names: C Sálek, C Šálek, C. Šálek, CYRIL ŠÁLEK, Cyril Salek, Salek, Cyril, Šálek, Cyril, Šálek C., Šálek Cyril, Šálek, Cyril
Observed institutions: Centre National de la Recherche Scientifique, Inserm, Université Paris Cité, Charles University, Génomes, biologie cellulaire et thérapeutiques, Institute of Haematology and Blood Transfusion, Genomac, Hôpital Saint-Louis
ORCID: 0000-0002-0021-3247
Observed ORCID: 0000-0002-0021-3247
OpenAlex ID: A5013446879
Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer
2015 · Jitka Fucikova, Irena Moserova, et al. · Frontiers in Immunology · 162
PDF
Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients
2016 · Jitka Fucikova, Iva Truxova, et al. · Blood · 140
DNA Methylation Validation Methods: a Coherent Review with Practical Comparison
2019 · Šárka Šestáková, Cyril Šálek, et al. · Biological Procedures Online · 124
PDF
High PD-L1 Expression Predicts for Worse Outcome of Leukemia Patients with Concomitant NPM1 and FLT3 Mutations
2019 · Barbora Brodská, Petra Otevřelová, et al. · International Journal of Molecular Sciences · 66
PDF
TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients
2021 · Jana Rakova, Iva Truxova, et al. · OncoImmunology · 62
Rapid identification of BCR / ABL 1‐like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time‐polymerase chain reaction: clinical, prognostic and therapeutic implications
2018 · Sabina Chiaretti, Monica Messina, et al. · British Journal of Haematology · 62
Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patients
2019 · Iva Truxova, Lenka Kasikova, et al. · Haematologica · 56
PDF
Novel Somatic UBA1 Variant in a Patient With VEXAS Syndrome
2023 · Blanka Stiburkova, Katerina Pavelcova, et al. · Arthritis & Rheumatology · 53
PDF
Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22 + Philadelphia Chromosome–Negative B-Cell Precursor Acute Lymphoblastic Leukemia
2024 · Patrice Chevallier, Thibaut Leguay, et al. · Journal of Clinical Oncology · 51
Mutation status of K-ras, p53 and allelic losses at 9p and 18q are not prognostic markers in patients with pancreatic cancer.
2009 · Cyril Salek, Petra Minarikova, et al. · PubMed · 33
Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients
2023 · Peter Holicek, Iva Truxova, et al. · Cell Death and Disease · 32
PDF
Early MRD response as a prognostic factor in adult patients with acute lymphoblastic leukemia
2015 · Cyril Šálek, František Folber, et al. · European Journal Of Haematology · 32
GATA-1 Inhibits PU.1 Gene via DNA and Histone H3K9 Methylation of Its Distal Enhancer in Erythroleukemia
2016 · Pavel Burda, Jarmila Vargova, et al. · PLoS ONE · 23
PDF
Minimal residual disease detectable by quantitative assessment of WT 1 gene before allogeneic stem cell transplantation in patients in first remission of acute myeloid leukemia has an impact on their future prognosis
2012 · Veronika Válková, Jaroslav Polák, et al. · Clinical Transplantation · 21
Chimeric Antigen Receptor Based Cellular Therapy for Treatment Of T-Cell Malignancies
2022 · Kamila Polgárová, Pavel Otáhal, et al. · Frontiers in Oncology · 19
Association of HLA class I type with prevalence and outcome of patients with acute myeloid leukemia and mutated nucleophosmin
2018 · Kateřina Kuželová, Barbora Brodská, et al. · PLoS ONE · 18
PDF
ABC transporters are predictors of treatment failure in acute myeloid leukaemia
2023 · Ela Cerovska, Cyril Salek, et al. · Biomedicine & Pharmacotherapy · 16
Fractionated Inotuzumab Ozogamicin Combined with Low-Intensity Chemotherapy Provides Very Good Outcome in Older Patients with Newly Diagnosed CD22+ Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia: First Results from the EWALL-INO Study
2021 · Patrice Chevallier, Thibault Leguay, et al. · Blood · 16
Estimation of molecular upper remission limit for monitoring minimal residual disease in peripheral blood of acute myeloid leukemia patients by WT1 expression
2011 · JAROSLAV POLÁK, HANA HÁJKOVÁ, et al. · Experimental and Therapeutic Medicine · 14
PDF
CBFB-MYH11 hypomethylation signature and PBX3 differential methylation revealed by targeted bisulfite sequencing in patients with acute myeloid leukemia
2014 · Hana Hájková, Markus Hsi-Yang Fritz, et al. · Journal of Hematology & Oncology · 12
PDF
A validation study of potential prognostic DNA methylation biomarkers in patients with acute myeloid leukemia using a custom DNA methylation sequencing panel
2022 · Šárka Šestáková, Ela Cerovská, et al. · Clinical Epigenetics · 11
PDF
Somatic Mutations in Oncogenes Are in Chronic Myeloid Leukemia Acquired De Novo via Deregulated Base-Excision Repair and Alternative Non-Homologous End Joining
2021 · Nikola Curik, Vaclava Polivkova, et al. · Frontiers in Oncology · 10
PDF
Comparison of Real-time Quantitative Polymerase Chain Reaction and Eight-color Flow Cytometry in Assessment of Minimal Residual Disease in Adult Acute Lymphoblastic Leukemia
2018 · Stepan Hrabovsky, Frantisek Folber, et al. · Clinical Lymphoma Myeloma & Leukemia · 10
NPM1 and DNMT3A mutations are associated with distinct blast immunophenotype in acute myeloid leukemia
2022 · Kateřina Kuželová, Barbora Brodská, et al. · OncoImmunology · 9
Sensitivity and reliability of DNA-based mutation analysis by allele-specific digital PCR to follow resistant BCR-ABL1-positive cells
2021 · Vaclava Polivkova, Adela Benesova, et al. · Leukemia · 9
Works count: 108
Citation count: 1,214
H-index: 17
I10-index: 24
Year
Topic
Type